The FDA lifted its clinical hold on Novavax's COVID-flu vaccine trial. The hold was due to unrelated safety concerns, allowing trial resumption. Novavax aims for growth with its combination shot ...

Novavax (NASDAQ:NVAX) shares climbed 12% premarket on Monday after the U.S. FDA lifted clinical hold on the investigational new drug application for the pharma firm’s COVID-19-Influenza ...

The Food and Drug Administration halted Novavax's trial of a combination vaccine for COVID and influenza, as well as a standalone flu shot, after a participant suffered a serious adverse event ...

The U.S. Food and Drug Administration has put Novavax's trial of an experimental COVID-flu vaccine combination on hold after one person who received the shot reported nerve damage, the company ...

The U.S. Food and Drug Administration has put a trial of Novavax’s COVID-influenza and its standalone flu vaccines on hold after a participant who took the combination shot reported nerve damage ...

The clinical hold does not impact the COVID-19 IND for Novavax’s COVID-19 vaccine. In April 2022, Novavax announced initial results from the Phase 1/2 trial of its CIC Vaccine.

As a result, the FDA has put the brakes on Novavax’s plans to launch a phase 3 trial of both the combo shot and a standalone flu vaccine later this year.

Novavax’s deal with Sanofi also allows the latter to combine its own influenza vaccines with Nuvaxovid. Sanofi is currently testing multiple COVID-19/flu combination vaccine candidates under ...

Novavax’s closely watched COVID-19 vaccine is on track for full approval after additional discussions with the Food and Drug Administration, the company said Wednesday.

WASHINGTON — The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with unusual restrictions. Novavax makes the nation’s only traditional ...

The U.S. Food and Drug Administration has put on hold a trial of Novavax's COVID-influenza and its standalone flu vaccines after a participant who took the combination shot reported nerve damage ...

Novavax (NVAX) shares surge 12% as FDA lifts clinical hold on COVID-19-Influenza Combination ... Novavax climbs as FDA lifts clinical hold on Covid, flu combo trials. Nov. 11, 2024 9:18 AM ET ...